In vitro adrenergic modulation of cellular immune functions in experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 146, Issue 1-2, 2004, Pages 126-132

  Haerter, Katharina ^a   Vroon, Anne ^b   Kavelaars, Annemieke ^b   Heijnen, Cobi J ^b   Limmroth, Volker ^c   Espinosa, Enrique ^a   Schedlowski, Manfred ^a,d   Elsenbruch, Sigrid ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d ETH ZURICH   (Switzerland)

Author keywords

Adrenoceptor agonists; Experimental autoimmune encephalomyelitis; Macrophages; Proinflammatory cytokines; Splenocytes

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CONCANAVALIN A; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; METHOXAMINE; TERBUTALINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; IMMUNOLOGY; INFLAMMATION; METABOLISM; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; REMISSION; SPLEEN CELL;

EID: 0347993166     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.051     Document Type: Article

References (50)

1. Ackerman K.D., Heyman R., Rabin B.S., Anderson B.P., Houck P.R., Frank E., Baum A. Stressful life events precede exacerbations of multiple sclerosis. Psychosom. Med. 64:2002;916-920.
2. Ackerman K.D., Stover A., Heyman R., Anderson B.P., Houck P.R., Frank E., Rabin B., Baum A. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav. Immun. 17:2003;141-151.
3. Brosnan C.F., Goldmuntz E.A., Cammer W., Factor S.M., Bloom B.R., Norton W.T. Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Proc. Natl. Acad. Sci. U. S. A. 82:1985;5915-5919.
4. Brosnan C.F., Sacks H.J., Goldschmidt R.C., Goldmuntz E.A., Norton W.T. Prazosin treatment during the effector stage of disease suppresses experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 137:1986;3451-3456.
5. Brosnan C.F., Selmaj K., Raine C.S. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 18:1988;87-94.
6. Chelmicka-Schorr E., Checinski M., Arnason B.G. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 17:1988;347-350.
7. Chelmicka-Schorr E., Kwasniewski M.N., Wollmann R.L. Sympathectomy augments adoptively transferred experimental autoimmune encephalomyelitis. J. Neuroimmunol. 37:1992;99-103.
8. Chelmicka-Schorr E., Kwasniewski M.N., Czlonkowska A. Sympathetic nervous system modulates macrophage function. Int. J. Immunopharmacol. 14:1992;841-846.
9. Chou R.C., Stinson M.W., Nobe B.K., Spengler R.N. β-Adrenergic receptor regulation of macrophage-derived tumor necrosis factor-α production from rats with experimental arthritis. J. Neuroimmunol. 67:1996;7-16.
10. Chou R.C., Dong X.L., Noble B.K., Knight P.R., Spengler R.N. Adrenergic regulation of macrophage-derived tumor necrosis factor-α generation during a chornic polyarthritis pain model. J. Neuroimmunol. 82:1998;140-148.
11. De Keyser J., Wilczak N., Leta R., Streetland C. Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology. 53:1999;1628-1633.
12. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:2000;595-638.
13. Goldmuntz E.A., Brosnan C.F., Norton W.T. Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 137:1986;3444-3450.
14. Griffin A.C., Lo W.D., Wolny A.C., Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis by restraint stress: sex differences. J. Neuroimmunol. 44:1993;103-116.
15. Heesen C., Gold S.M., Sondermann J., Tessmer W., Schulz K.H. Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls. J. Neuroimmunol. 132:2002;189-195.
16. Heijnen C.J., Rouppe van der Voort C., Wulffraat N., van der Net J., Kuis W., Kavelaars A. Functional alpha 1-adrenoceptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 71:1996;223-226.
17. Heneka M.T., Sharp A., Murphy P., Lyons J.A., Dumitrescu L., Feinstein D.L. The heat shock response reduces myelin oligodendrocyte glycoprotein- induced experimental autoimmune encephalomyelitis in mice. J. Neurochem. 77:2001;568-579.
18. Herrmann M., Scholmerich J., Straub R.H. Stress and rheumatic diseases. Rheum. Dis. Clin. North Am. 26:2000;737-763.
19. Hetier E., Ayala J., Bousseau A., Prochiantz A. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenoceptor agonists in mouse ameboid microglial cells. Exp. Brain Res. 86:1991;407-413.
20. Ignatowski T.A., Gallant S., Spengler R.N. Temporal regulation by adrenergic receptor stimulation of macrophage (Mφ)-derived tumor necrosis factor (TNF) production post-LPS challenge. J. Neuroimmunol. 65:1996;107-117.
21. Karaszewski J.W., Reder A.T., Maselli R., Brown M., Arnason B.G. Sympathetic skin responses are decreased and lymphocyte beta-adrenoceptors are increased in progressive multiple sclerosis. Ann. Neurol. 27:1990;366-372.
22. Karaszewski J.W., Reder A.T., Anlar B., Kim W.C., Arnason B.G. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. Ann. Neurol. 30:1991;42-47.
23. Karaszewski J.W., Reder A.T., Anlar B., Arnason G.B. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J. Neuroimmunol. 43:1993;1-7.
24. Kavelaars A. Regulated expression of a-1 adrenoceptors in the immune system. Brain Behav. Immun. 16:2002;799-807.
25. + T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53:2001;487-525.
26. Kuroda Y., Mori T., Hori T. Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Res. Bull. 34:1994;15-17.
27. Leonard J.P., MacKenzie F.J., Patel H.A., Cuzner M.L. Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis. Brain Behav. Immun. 5:1991;328-338.
28. Levine S., Saltzman A. Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats. Brain Behav. Immun. 1:1987;336-341.
29. Lombardi M.S., Kavelaars A., Schedlowski M., Bijlsma J.W., Okihara K.L., Van de Pol M., Ochsmann S., Pawlak C., Schmidt R.E., Heijnen C.J. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 13:1999;715-725.
30. Lu C.Z., Jensen M.A., Arnason B.G. Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J. Neuroimmunol. 46:1993;123-128.
31. Maisel A.S., Fowler P., Rearden A., Motulsky H.J., Michel M.C. A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenoceptors by terbutaline treatment. Clin. Pharmacol. Ther. 46:1989;429-439.
32. Makhlouf K., Comabella M., Imitola J., Weiner H.L., Khoury S.J. Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis. J. Neuroimmunol. 117:2001;156-165.
33. Makhlouf K., Weiner H.L., Khoury S.J. Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol). CNS Drugs. 16:2002;1-8.
34. Mohr D.C., Goodkin D.E., Nelson S., Cox D., Weiner M. Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom. Med. 64:2002;803-809.
35. Muthyala S., Wiegmann K., Kim D.H., Arnason B.G., Chelmicka-Schorr E. Experimental allergic encephalomyelitis, beta-adrenoceptors and interferon gamma-secreting cells in beta-adrenoceptor agonist-treated rats. Int. J. Immunopharmacol. 17:1995;895-901.
36. Olsson T. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 40:1992;211-218.
37. Pal E., Tabira T. Autonomic regulation of experimental autoimmune encephalomyelitis: the role of interferon-gamma. Neuroimmunomodulation. 10:2002-2003;80-84.
38. Pawlak C.R., Witte T., Heiken H., Hundt M., Schubert J., Wiese B., Bischoff-Renken A., Gerber K., Licht B., Goebel M.U., Heijnen C.J., Schmidt R.E., Schedlowski M. Flares in patients with systemic lupus erythematosus are associated with daily psychological stress. Psychother. Psychosom. 72:2003;159-165.
39. Plaut M. Lymphocyte hormone receptors. Annu. Rev. Immunol. 5:1987;621-669.
40. Sanders V.M., Straub R.H. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 16:2002;290-332.
41. Schwartz C.E., Foley F.W., Rao S.M., Bernardin L.J., Lee H., Genderson M.W. Stress and course of disease in multiple sclerosis. Behav. Med. 25:1999;110-116.
42. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
43. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., Kunkel S.L. Stimulation of a-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145:1990;1430-1434.
44. van Boxel-Dezaire A.H., Hoff S.C., van Oosten B.W., Verweij C.L., Drager A.M., Ader H.J., van Houwelingen J.C., Barkhof F., Polman C.H., Nagelkerken L. Decreased interleukin-10 and increased interleukin-12 p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45:1999;695-703.
45. Vroon A., Lombardi M.S., Kavelaars A., Heijnen C.J. Changes in the G-protein-coupled receptor desensitization machinery during relapsing- progressive experimental allergic encephalomyelitis. J. Neuroimmunol. 137:2003;79-86.
46. White S.R., Black P.C., Samathanam G.K., Paros K.C. Prazosin suppresses development of axonal damage in rats inoculated for experimental allergic encephalomyelitis. J. Neuroimmunol. 39:1992;211-218.
47. Wiegmann K., Muthyala S., Kim D.H., Arnason B.G., Chelmicka-Schorr E. Beta-adrenoceptor agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol. 56:1995;201-206.
48. Xie Y., Frede S., Harnish M.J., Exton M.S., Schedlowski M. Beta-adrenoceptor-induced inhibition of rat splenocyte proliferation: cytokine gene transcription as the target of action. Immunobiology. 206:2002;345-353.
49. Zoukos Y., Leonard J.P., Thomaides T., Thompson A.J., Cuzner M.L. Beta-adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1. Ann. Neurol. 31:1992;657-662.
50. Zoukos Y., Kidd D., Woodroofe M.N., Kendall B.E., Thompson A.J., Cuzner M.L. Increased expression of high affinity IL-2 receptors and β-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain. 117:1994;307-315.